Digestive Diseases and Sciences

, Volume 58, Issue 7, pp 2038–2045 | Cite as

MYO5B Is Epigenetically Silenced and Associated with MET Signaling in Human Gastric Cancer

Original Article



Our previous study has shown that MYO5B is downregulated in gastric cancer. However, the mechanism by which the expression of MYO5B was inhibited remains unknown.


Inspection of the human MYO5B locus uncovered a large and dense CpG island within the 5′ region of this gene. Methylation-specific PCR (MSP) and bisulfite sequencing (BSP) were used for determination of MYO5B promoter methylation in gastric cancer cell lines and gastric cancer samples. Involvement of histone H3 methylation in those cell lines were examined by ChIP assay.


The densely methylated MYO5B promoter region was confirmed by MSP and BSP. Enhanced gene expression was detected when the cells were treated with the DNA-demethylating agent 5-aza-2′-deoxycytidine (DAC) and trichostatin A (TSA), a histone deacetylase inhibitor. Knockdown of MYO5B expression in gastric cancer cells expressing endogenous MYO5B inhibits HGF-stimulated MET degradation, concomitant with sustained c-MET levels and signaling.


The results of our study showed for the first time that MYO5B is epigenetically silenced in gastric cancer cells by aberrant DNA methylation and histone modification. Inactivation of MYO5B expression in gastric cancer cells expressing endogenous MYO5B inhibits HGF-stimulated MET degradation, concomitant with sustained c-MET levels and signaling.


MYO5B MET Methylation Gastric cancer 



This work was supported by the youth innovation fund of the first affiliated hospital of Zhengzhou University.

Conflict of interest


Supplementary material

After treatments with DAC or/and TSA, the MKN45 and MKN28 cells were harvested. The protein levels of MYO5B were determined by Western blot, with Actin serving as internal control.

10620_2013_2600_MOESM1_ESM.jpg (64 kb)
Supplementary material 1 (JPEG 64 kb)

Immunohistochemical staining for MYO5B with anti- MYO5B in the 4 gastric cancer tissues (T6, T13, T35 and T60). The nuclei were countered stained with hematoxylin. Case numbers are shown on top. (B) Demonstration of MYO5B promoter methylation by sequencing of sodium bisulfite–modified DNA from the 4 cancerous tissues. The case numbers are shown on left.

10620_2013_2600_MOESM2_ESM.jpg (975 kb)
Supplementary material 2 (JPEG 975 kb)


  1. 1.
    Lapierre LA, Kumar R, Hales CM, et al. Myosin vb is associated with plasma membrane recycling systems. Mol Biol Cell. 2001;12:1843–1857.PubMedGoogle Scholar
  2. 2.
    Roland JT, Bryant DM, Datta A, Itzen A, Mostov KE, Goldenring JR. Rab gtpase-myo5b complexes control membrane recycling and epithelial polarization. Proc Natl Acad Sci USA. 2011;108:2789–2794.PubMedCrossRefGoogle Scholar
  3. 3.
    Muller T, Hess MW, Schiefermeier N, et al. Myo5b mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet. 2008;40:1163–1165.PubMedCrossRefGoogle Scholar
  4. 4.
    Dong W, Chen X, Chen P, Yue D, Zhu L, Fan Q. Inactivation of myo5b promotes invasion and motility in gastric cancer cells. Dig Dis Sci. 2012;57:1247–1252.PubMedCrossRefGoogle Scholar
  5. 5.
    Shen R, Pan S, Qi S, Lin X, Cheng S. Epigenetic repression of microrna-129-2 leads to overexpression of sox4 in gastric cancer. Biochem Biophys Res Commun. 2010;394:1047–1052.PubMedCrossRefGoogle Scholar
  6. 6.
    Kuang SQ, Tong WG, Yang H, et al. Genome-wide identification of aberrantly methylated promoter associated cpg islands in acute lymphocytic leukemia. Leukemia. 2008;22:1529–1538.PubMedCrossRefGoogle Scholar
  7. 7.
    Parachoniak CA, Luo Y, Abella JV, Keen JH, Park M. Gga3 functions as a switch to promote met receptor recycling, essential for sustained erk and cell migration. Dev Cell. 2011;20:751–763.PubMedCrossRefGoogle Scholar
  8. 8.
    Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH. Aberrant methylation of the fhit gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis. 2004;25:2165–2171.PubMedCrossRefGoogle Scholar
  9. 9.
    Dong W, Chen X, Xie J, Sun P, Wu Y. Epigenetic inactivation and tumor suppressor activity of hai-2/spint2 in gastric cancer. Int J Cancer. 2010;127:1526–1534.PubMedCrossRefGoogle Scholar
  10. 10.
    Nakayama S, Semba S, Maeda N, Matsushita M, Kuroda Y, Yokozaki H. Hypermethylation-mediated reduction of wwox expression in intraductal papillary mucinous neoplasms of the pancreas. Br J Cancer. 2009;100:1438–1443.PubMedCrossRefGoogle Scholar
  11. 11.
    Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM. Frequent downregulation and loss of wwox gene expression in human hepatocellular carcinoma. Br J Cancer. 2004;91:753–759.PubMedGoogle Scholar
  12. 12.
    Yan J, Zhang M, Zhang J, Chen X, Zhang X. Helicobacter pylori infection promotes methylation of wwox gene in human gastric cancer. Biochem Biophys Res Commun. 2011;408:99–102.PubMedCrossRefGoogle Scholar
  13. 13.
    Fan GH, Lapierre LA, Goldenring JR, Sai J, Richmond A. Rab11-family interacting protein 2 and myosin vb are required for cxcr2 recycling and receptor-mediated chemotaxis. Mol Biol Cell. 2004;15:2456–2469.PubMedCrossRefGoogle Scholar
  14. 14.
    Lise MF, Wong TP, Trinh A, et al. Involvement of myosin vb in glutamate receptor trafficking. J Biol Chem. 2006;281:3669–3678.PubMedCrossRefGoogle Scholar
  15. 15.
    Swiatecka-Urban A, Talebian L, Kanno E, et al. Myosin vb is required for trafficking of the cystic fibrosis transmembrane conductance regulator in rab11a-specific apical recycling endosomes in polarized human airway epithelial cells. J Biol Chem. 2007;282:23725–23736.PubMedCrossRefGoogle Scholar
  16. 16.
    Chu BB, Ge L, Xie C, et al. Requirement of myosin vb.Rab11a.Rab11-fip2 complex in cholesterol-regulated translocation of npc1l1 to the cell surface. J Biol Chem. 2009;284:22481–22490.PubMedCrossRefGoogle Scholar
  17. 17.
    Millman EE, Zhang H, Zhang H, et al. Rapid recycling of beta-adrenergic receptors is dependent on the actin cytoskeleton and myosin vb. Traffic. 2008;9:1958–1971.PubMedCrossRefGoogle Scholar
  18. 18.
    Chen CT, Kim H, Liska D, Gao S, Christensen JG, Weiser MR. Met activation mediates resistance to lapatinib inhibition of her2-amplified gastric cancer cells. Mol Cancer Ther. 2012;11:660–669.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Internal Medicine-Oncology, The First Affiliated HospitalZhengzhou UniversityZhengzhouChina
  2. 2.Department of Gastroenterology, Rui-jin HospitalShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations